Omalizumab is effective in nonautoimmune urticaria

MeSH terms

• Adult
• Anti-Allergic Agents / administration & dosage
• Anti-Allergic Agents / therapeutic use*
• Antibodies, Anti-Idiotypic / administration & dosage
• Antibodies, Anti-Idiotypic / therapeutic use*
• Antibodies, Monoclonal / administration & dosage
• Antibodies, Monoclonal / therapeutic use*
• Antibodies, Monoclonal, Humanized
• Chronic Disease
• Drug Administration Schedule
• Female
• Humans
• Male
• Middle Aged
• Omalizumab
• Severity of Illness Index
• Treatment Outcome
• Urticaria / drug therapy*
• Urticaria / physiopathology
• Young Adult